antagonistic anti-CD28 antibody (Bristol-Myers Squibb)

N/A

Report date: 2025/03/14 16:54:49

Base Information

Drug Nameantagonistic anti-CD28 antibody (Bristol-Myers Squibb)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT-cell-specific surface glycoprotein CD28 inhibitors
TargetsT-cell-specific surface glycoprotein CD28
Therapy Area/IndicationsGiant Cell Arteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsGiant Cell Arteritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A